Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Oct 17;1038:1–11. doi: 10.1016/j.jchromb.2016.10.014

Table 1.

Compounds identified from ginseng extract

No
.
Name RT
(min
)
Formul
a
MW
(Da)
Measu
red
(Da)a
Err
or
(pp
m)
Main MS/MS fragment
ions
Ref
.
1 Majonoside
R1/isomer
3.21
1
C42H72
O15
816.48
72
815.48
15
2.5 653.4313 [M−H−Glc];
635.4169 [M−H−Glc−H2O];
491.3742 [M−H−2Glc]
27
2 Notoginsenoside
N1/isomer
3.64
3
C48H82
O19
962.54
5
961.54
05
3.4 799.4956
[M−H−Glc];781.4812
[M−H−Glc−H2O]
27
3 Majonoside
R1/isomer
6.31
1
C42H72
O15
816.48
72
815.48
00
0.7 653.4299 [M−H−Glc];
635.4299 [M−H−Glc−H2O];
491.3761 [M−H−2Glc]
27
4 20-glc-Rf 7.43
2
C48H82
O19
962.54
50
961.53
85
1.4 799.4893 [M−H−Glc];
637.4316 [M−H−2Glc];
475.3767 [M−H−3Glc]
23,
25
5 Notoginsenoside
R1
7.85
1
C47H80
O18
932.53
45
931.52
75
0.8 799.4871 [M−H−Glc];
637.4315 [M−H−Araf−Glc];
475.3794
[M−H−Araf−2Glc]
23,
28
6 Ginsenoside Rg1 8.58
5
C42H72
O14
800.49
22
799.48
68
2.4 637.4321 [M−H−Glc];
475.3798 [M−H−2Glc]
23,
28
7 Ginsenoside Re 8.64
5
C48H82
O18
946.55
01
945.54
58
3.2 799.4918 [M−H−Rha];
783.4956 [M−H−Glc];
637.4348 [M−H−Rha−Glc];
475.3806 [M−H−Rha−Glc]
23,
28
8 Notoginsenoside
A/isomer
9.92
3
C54H92
O24
1124.5
979
1123.5
901
0 961.5431 [M−H−Glc];
799.4781 [M−H−2Glc];
781.4802
[M−H−2Glc−H2O]
27
9 Ginsenoside Rf 13.2
36
C42H72
O14
800.49
22
799.48
19
−3.1 637.432 [M−H−Glc];
475.3768 [M−H−2Glc]
23,
28
10 Bu-Rg1 13.3
57
C46H76
O15
868.51
84
867.51
34
3.2 799.4899 [M−H−Bu];
637.4337 [M−H−Bu−Glc];
475.3741 [M−H−Bu−2Glc]
22
11 Ginsenoside Ra3 13.8
98
C59H100
O27
1240.6
452
1239.6
330
−3.5 1107.6207 [M−H−Xyl];
945.5357 [M−H−Xyl−Glc];
783.5173
[M−H−Xyl−2Glc];
621.4370
[M−H−Xyl−3Glc];
459.3882 [M−H−Xyl−4Glc]
28
12 Notoginsenoside
Fa
13.9
64
C59H100
O27
1240.6
452
1239.6
319
−4.4 1107.5786 [M−H−Xyl];
945.5450 [M−H−Xyl−Glc];
783.4880
[M−H−Xyl−2Glc];
621.4380
[M−H−Xyl−3Glc];
459.3845 [M−H−Xyl−4Glc]
24
13 Notoginsenoside
R2
14.5
32
C41H70
O13
770.48
16
769.47
20

2.3
637.4273 [M−H−Xyl];
475.3757 [M−H−Xyl−Glc]
23,
28
14 Ginsenoside Rg2 16.3
16
C42H72
O13
784.49
73
783.48
70
−3.2 637.4311 [M−H−Rha];
475.3781 [M−H−Rha−Glc]
23,
28
15 Ginsenoside Rh1 16.5
47
C36H62
O9
638.43
94
637.43
30
1.4 475.3765 [M−H−Glc] 23,
28
16 Bu-Re 16.8
54
C52H86
O19
1014.5
763
1013.5
708
2.3 945.5451 [M−H−Bu];
799.4853 [M−H-Bu−Rha];
637.4331
[M−H-Bu−Rha−Glc];
475.3772
[M−H-Bu−Rha−2Glc]
22
17 Ginsenoside Ra1 17.3
41
C58H98
O26
1210.6
346
1209.6
272
0.3 1077.6158 [M−H−Xyl];
945.5423
[M−H−Xyl−Arap];
783.4917
[M−H−Xyl−Arap−Glc];
765.4602
[M−H−Xyl−Arap−Glc−H2O]
; 621.4410
[M−H−Xyl−Arap−2Glc];
459.3818
[M−H−Xyl−Arap−3Glc]
28
18 Bu-Rf 17.6
88
C46H76
O15
868.51
84
867.51
13
0.8 799.5486[M−H−Bu];
637.4282 [M−H−Bu−Glc];
475.3801 [M−H−Bu−2Glc]
22
19 Ginsenoside Rb1 18.1
90
C54H92
O23
1108.6
029
1107.5
911
−3.6 945.5507 [M−H−Glc];
783.4896 [M−H−2Glc];
621.4381 [M−H−3Glc];
459.3838 [M−H−4Glc]
23,
28
20 Malonyl-Rb1 20.3
06
C57H94
O26
1194.6
033
1193.5
993
2.8 1107.6072 [M−H−mal];
945.5593 [M−H−mal−Glc];
783.4674
[M−H−mal−2Glc];
765.4901
[M−H−mal-2Glc−H2O];
621.4435 [M−H−mal−3Glc]
23,
28
21 Ginsenoside Rc 20.7
34
C53H90
O22
1078.5
924
1077.5
846
0 945.0000 [M−H−Araf];
783.0000 [M−H−Araf−Glc];
621.0000
[M−H−Araf−2Glc];
459.3812
[M−H−Araf−3Glc]
23,
28
22 Ginsenoside Ro 20.9
29
C48H76
O19
956.49
81
955.47
36
−1.7 955.4828 [M−H]; 793.4456
[M−H−Glc];
713.427[M−H−Glc−CO2−H2
O]; 613.3784
[M−H-2Glc−H2O];
569.3766
[M−H−2Glc−CO2−H2O];
455.3549
[M−H-3Glc−Acid]
23,
28
23 Ginsenoside Ra2 21.7
08
C58H98
O26
1210.6
346
1209.6
202
1.7 1077.6158 [M−H−Xyl];
945.5381
[M−H−Xyl−Araf];
783.4853
[M−H−Xyl−Araf−Glc];
765.4739
[M−H−Xyl−Araf−Glc−H2O]
; 621.4294
[M−H−Xyl−Araf−Glc−H2O]
; 459.3787
[M−H−Xyl−Araf−3Glc]
28
24 Ginsenoside F1 23.5
59
C36H62
O9
638.43
94
637.43
39
3.6 475.3816 [M−H−Glc] 28
25 Malonyl-Rc 23.8
07
C56H92
O25
1164.5
928
1163.5
887
2.7 1119.5898 [M−H−CO2];
1077.577 [M−H−mal];
945.5308 [M−H−mal-Araf];
783.4829
[M−H−mal-Araf−Glc];
621.4227
[M−H−mal-Araf−2Glc];
459.3813
[M−H−mal-Araf−3Glc]
23,
28
26 Malonyl-Rb2 23.9
27
C56H92
O25
1164.5
928
1163.5
867
1.0 1119.5893 [M−H−CO2];
1077.5760
[M−H−mal-Arap]; 945.5363
[M−H−mal-Arap]; 783.4904
[M−H−mal-Arap−Glc];
621.4354
[M−H−mal-Arap−2Glc]
23,
28
27 Malonyl-Ra1/
Malonyl-Ra2
24.5
01
C61H100
O29
1296.6
350
1295.6
299
1.7 1209.6272 [M−H−mal];
1077.6158
[M−H−mal−Xyl]; 945.5423
[M−H−mal−Xyl−Ara];
783.4917[M−H−mal−Xyl−A
ra−Glc]; 765.4602
[M−H−mal]−Xyl−Ara−Glc−
H2O];
621.4410[M−H−mal]−Xyl−
Ara−2Glc];
459.3818[M−H−mal−Xyl−A
ra−3Glc]
28
28 Ginsenoside Rb2 25.0
78
C53H90
O22
1078.5
824
1077.5
761
0.9 945.5345 [M−H−Arap];
783.4844
[M−H−Arap−Glc];
621.4313
[M−H−Arap−2Glc];
459.3813
[M−H−Arap−3Glc]
23,
28
29 Ginsenoside Rb3 26.7
16
C53H90
O22
1078.5
924
1077.5
846
0 945.0000 [M−H−Xyl];
783.0000 [M−H−Xyl−Glc];
621.4186
[M−H−Xyl−2Glc];
459.3711 [M−H−Xyl−3Glc]
23,
28
30 Malonyl-Rb3 27.8
90
C56H92
O25
1164.5
928
1163.5
896
3.5 1119.5832 [M−H−CO2];
1077.5738 [M−H−mal];
945.5557 [M−H−mal−Xyl];
783.4785
[M−H−mal−Xyl−Glc];
621.4281
[M−H−mal−Xyl−2Glc]
23,
28
31 Notoginsenoside
Fc
28.2
78
C58H98
O26
1210.6
346
1209.6
222
−3.8 1077.6158 [M−H−Xyl];
945.5410
[M−H−Xyl−Arap];
783.4793
[M−H−Xyl−Arap−Glc];
621.4312
[M−H−Xyl−Arap−2Glc];
459.3830
[M−H−Xyl−Arap−3Glc]
24
32 Quinquenoside R1 28.7
63
C56H94
O24
1150.6
135
1149.6
118
−2.8 1107.5836 [M−H−AC];
1089.5745
[M−H−AC−H2O]; 945.5285
[M−H−AC−Glc]; 783.4795
[M−H−AC−2Glc];
621.4282
[M−H−AC−3Glc];
459.3848 [M−H−AC−4Glc]
24
33 Chikusetsusaponi
n IVa
29.2
61
C42H66
O14
794.44
53
793.44
06
3.9 631.3770 [M−H−Glc];
613.7845 [M−H−Glc−H2O];
569.3789
[M−H−2Glc−CO2−H2O];
455.3485
[M−H−2Glc−Acid]
21,
29
34 Ginsenoside Rd 29.5
32
C48H82
O18
946.55
01
945.54
57
3.0 783.4816 [M−H−Glc];
621.4299 [M−H−2Glc];
459.3781 [M−H−3Glc]
23,
28
35 Ginsenoside Rs1 29.8
93
C55H92
O23
1120.6
029
1119.5
993
3.3 1077.5668 [M−H−Ac];
945.5472 [M−H−Ac−Arap];
783.4679
[M−H−Ac−Arap−Glc];
621.4302
[M−H−Ac−Arap−2Glc];
459.3709
[M−H−Ac−Arap−3Glc]
28
36 Malonyl-Rd 30.2
5
C51H84
O21
1032.5
505
1031.5
408
−1.8 987.5372 [M−H−CO2];
945.5301 [M−H−mal];
783.4829 [M−H−mal−Glc];
621.4292
[M−H−mal−2Glc];
459.3823 [M−H−mal−3Glc]
23,
28
37 Ginsenoside Rs2 30.6
49
C55H92
O23
1120.6
029
1119.6
003
4.6 1077.5742 [M−H−Ac];
945.5422 [M−H−Ac−Araf];
915.5121 [M−H−Ac−Glc];
783.4852
[M−H−Ac−Araf−Glc];
621.4312
[M−H−Ac−Araf−2Glc];
459.3818
[M−H−Ac−Araf−3Glc]
28
38 Gypenoside XVII 31.0
41
C48H82
O18
946.55
01
945.54
24
−0.4 783.4831 [M−H−Glc];
621.4288 [M−H−2Glc];
459.3804 [M−H−3Glc]
26
39 ginsenoside Ra6 31.1
36
C58H96
O24
1176.6
075
1175.6
025
2.0 1107.5847 [M−H−Bu];
945.5311 [M−H-Bu−Glc];
783.4826 [M−H-Bu−2Glc];
621.4338 [M−H-Bu−3Glc];
459.3887 [M−H-Bu−4Glc]
22
40 ginsenoside Ra7 31.7
48
C57H94
O23
1146.6
186
1145.6
150
3.7 1077.5731 [M−H−Bu];
945.5274 [M−H−Bu−Araf];
783.4809
[M−H−Bu−Araf−Glc];
621.4315
[M−H−Bu−Araf−2Glc];
459.3795
[M−H−Bu−Araf−3Glc]
22
41 Compound Mc-1 31.8
68
C47H80
O17
916.53
90
915.52
99
−2.0 783.4833 [M−H−Araf];
621.4284 [M−H−Araf−Glc];
459.3816
[M−H−Araf−2Glc]
26
42 Compound O 32.0
33
C47H80
O17
916.53
90
915.53
00
−1.9 783.4795 [M−H−Arap];
621.4306
[M−H−Arap−Glc];
459.3778
[M−H−Arap−2Glc]
26
43 Pseudoginsenosid
e Rc1
32.1
24
C50H84
O19
988.56
07
987.55
61
3.2 945.5316 [M−H−AC];
783.4837 [M−H−AC−Glc];
621.4302
[M−H−AC−2Glc];
459.3802 [M−H−AC−3Glc]
26
44 ginsenoside
Ra8/Ra9
32.3
05
C57H94
O23
1146.6
18
1145.6
155
4.2 1077.5731 [M−H−Bu];
945.5274 [M−H−Bu−Araf];
783.4809
[M−H−Bu−Araf−Glc];
621.4315
[M−H−Bu−Araf−2Glc];
459.3795
[M−H−Bu−Araf−3Glc]
22
45 Gypenoside IX 32.4
46
C47H80
O17
916.53
90
915.53
52
3.8 961.5394 [M+HCOO];
783.4812 [M−H−Xyl];
621.4284 [M−H−Xy−Glc];
459.3864 [M−H−Xy−2Glc]
26
46 Bu-Gypenoside
XVII
33.7
09
C52H86
O19
1014.5
757
1013.5
650
−3.4 945.5287 [M−H−Bu];
783.4796 [M−H-Bu−Glc];
621.4307 [M−H-Bu−2Glc];
459.3760 [M−H-Bu−3Glc]
22
47 20(S)-Ginsenosid
e Rg3/isomer
34.0
69
C42H72
O13
784.49
73
783.48
86
−1.8 621.4291 [M−H−Glc];
459.3784 [M−H−2Glc]
23,
28
48 Zingibroside R1 34.6
13
C42H66
O14
794.44
53
793.44
10
4.4 631.3742 [M−H−Glc];
613.3672 [M−H−Glc−H2O];
569.3779
[M−H−2Glc−CO2−H2O];
455.3474
[M−H−2Glc−Acid]
26,
29
49 Bu-Rd 34.7
09
C52H86
O19
1014.5
763
1013.5
672
−1.3 945.5314 [M−H−Bu];
783.4778 [M−H-Bu−Glc];
621.4255 [M−H-Bu−2Glc];
459.3775[M−H-Bu−3Glc]
22
50 20(R)-Ginsenosid
e Rg3/isomer
35.5
36
C42H72
O13
784.49
73
783.49
27
3.4 621.4245 [M−H−Glc];
459.3759 [M−H−2Glc]
23,
28
51 24(R)-pseudogins
enoside RT5
38.6
59
C33H58
O14
678.38
27
677.37
60
1.6 677.3823 [M−H]; 24
52 Ginsenoside Rk1 39.3
51
C42H70
O12
766.48
67
765.47
69
−2.6 03.4125 [M−H−Glc] 23,
28
53 Ginsenoside Rg5 39.7
82
C42H70
O12
766.48
67
765.47
59
−3.9 603.4125 [M−H−Glc] 23,
28
54 Ginsenoside Rh2 40.1
17
C36H62
O8
622.44
45
621.43
86
3.1 459.3792 [M−H−Glc] 23,
28
a

[M−H];

Glc=β-D-glucopyranosyl (162 Da); Rha=α-L-rhamnopyranosyl (146 Da);

Ara=β-D-arabopyranosyl (132 Da); Xyl=β-D-Xylopyranosyl (132 Da);

Glc-Acid=β-D-glucopyranosylacetyl acid (176 Da); Ac=acetyl (42 Da); Bu=trans-but-2-enoyl (68 Da); Mal=malonyl (86 Da).